Benzinga
Benzinga
Benzinga
jueves, septiembre 17

LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc.

LIPOOTCEM
Trade with Public
Trade with Public
$2.36
-0.35-12.75%
al cierre: Jun 17, 5:00 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadComparar

LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. (LIPO).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$16Upside to Avg. PT+3199900.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Apr 9, 2024Maxim GroupJason McCarthyInitiateBuy$2

Analyst Ratings News

PRO
Maxim Group Initiates Coverage On Lipella Pharmaceuticals with Buy Rating, Announces Price Target of $2

Maxim Group analyst Jason McCarthy initiates coverage on Lipella Pharmaceuticals (NASDAQ:LIPO) with a Buy rating and announces Price Target of $2.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved